Dec 18
|
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
|
Dec 18
|
BioNTech aims to start mRNA vaccine output in Rwanda in 2025
|
Dec 18
|
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024
|
Dec 8
|
12 Best Healthcare Stocks For the Long-Term
|
Dec 5
|
Do You Think the Decrease in Demand for COVID-19 Vaccine Boosters Impacted BioNTech SE (BNTX)?
|
Dec 1
|
BioNTech ADRs drop after JPMorgan lowers outlook to "underweight"
|
Nov 28
|
AWS expands big pharma partnerships in manufacturing, AI, and R&D
|
Aug 31
|
Pfizer (PFE) & BioNTech Get CHMP Nod for Updated Covid-19 Jab
|
Aug 30
|
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
|
Aug 30
|
UPDATE 2-EU regulators backs Pfizer's updated vaccine for dominant Omicron subvariant
|
Aug 30
|
Insiders own 20% of BioNTech SE (NASDAQ:BNTX) shares but private equity firms control 44% of the company
|
Aug 27
|
COVID Is Making a Comeback: Should You Buy These 2 Stocks?
|
Aug 25
|
VinFast, Arm and Other Index Orphans Miss Out on Billions From Passive Investors
|